Jowell Global Ltd (JWEL) FinancialsJWELJowell Global Ltd

Jowell Global Ltd (JWEL) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Health and Nutritional supplements, accounting for 59.4% of total sales, equivalent to $41.53M. Other significant revenue streams include Household products and Cosmetic products. Understanding this composition is critical for investors evaluating how JWEL navigates market cycles within the Department Stores industry.

Evaluating the bottom line, Jowell Global Ltd maintains a gross margin of 8.16%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -2.05%, while the net margin is -1.66%. These profitability ratios, combined with a Return on Equity (ROE) of -29.82%, provide a clear picture of how effectively JWEL converts its operational activities into shareholder value.

In the context of the broader market, JWEL competes directly with industry leaders such as RDGT and MEDS. With a market capitalization of $4.39M, it holds a leading position in the sector. When comparing efficiency, JWEL's gross margin of 8.16% stands against RDGT's 3.92% and MEDS's -9.80%. Such benchmarking helps identify whether Jowell Global Ltd is trading at a premium or discount relative to its financial performance.

In Q1 2025, Jowell Global reported total revenue of 47.3 million USD, but also a net income loss of 4.23 million USD, highlighting financial instability. The current ratio is strong at 2.38, indicating good short-term liquidity, while the debt-to-equity ratio is low at 13.14%, suggesting manageable debt levels.